There are errors in the Competing Interests statement. The correct Competing Interests statement is: The authors have the following conflicts to report: Dr. Kuo consults for Genova Diagnostics, Furiex, and Given Imaging. Dr. Kuo receives funding from Given and Furiex for clinical trials, unrelated to this particular study. Dr. Macklin serves on the DSMBs for Lantheus Medical Imaging, Shire Human Genetic Therapies, and Civitas Therapeutics. Dr. Denninger receives support for unrelated investigator-initiated studies from Onyx Pharmaceuticals and Basis. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The following authors hold or have held positions at the Benson-Henry Institute for Mind Body Medicine at Massachusetts General Hospital, which is paid by patients and their insurers for running the SMART-3RP and related relaxation/mindfulness clinical programs, markets related products such as books, DVDs, CDs and the like, and holds a patent pending (PCT/US2012/049539 filed August 3, 2012) entitled "Quantitative Genomics of the Relaxation Response": MB, JJ, MAS, LS, EIKR, VL, NNH, LK, ES, GLF, HB, TAL, JWD.
Reference
Citation: Kuo B, Bhasin M, Jacquart J, Scult MA, Slipp L, Riklin EIK, et al. (2017) Correction: Genomic and Clinical Effects Associated with a Relaxation Response Mind-Body Intervention in Patients with Irritable Bowel Syndrome and Inflammatory Bowel Disease. PLoS ONE 12(2): e0172872. https://doi.org/10.1371/journal.pone.0172872
Published: February 21, 2017
Copyright: © 2017 Kuo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.